Approval · Notice of Compliance 4823 · 2004
CESAMET: Notice of Compliance 4823
Issued July 29, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4823
- Date
- July 29, 2004
- Company
- Icn Canada Ltd.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 0.5mg capsules
- Therapeutic class
- Antiemetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CESAMET | 02256193 | Marketed |
Medicinal ingredients
- NABILONE 0.5 MG per CAP